Europe - Euronext Milan - BIT:1LLY - US5324571083 - Common Stock
1LLY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. 1LLY scores excellent on profitability, but there are some minor concerns on its financial health. 1LLY is valued quite expensive, but it does show an excellent growth. This makes 1LLY very considerable for growth investing!
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROIC | 28.84% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 8.38 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.23 | ||
| Fwd PE | 32.02 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 155.78 | ||
| EV/EBITDA | 36.6 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.64% |
ChartMill assigns a fundamental rating of 6 / 10 to 1LLY.MI.
ChartMill assigns a valuation rating of 3 / 10 to ELI LILLY & CO (1LLY.MI). This can be considered as Overvalued.
ELI LILLY & CO (1LLY.MI) has a profitability rating of 9 / 10.
The Earnings per Share (EPS) of ELI LILLY & CO (1LLY.MI) is expected to grow by 84.93% in the next year.
The dividend rating of ELI LILLY & CO (1LLY.MI) is 4 / 10 and the dividend payout ratio is 28.28%.